Literature DB >> 9561027

Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells.

J Murata1, K Ayukawa, M Ogasawara, H Fujii, I Saiki.   

Abstract

We have examined the effect of alpha-melanocyte-stimulating hormone (alpha-MSH) on invasive ability of murine melanoma cell lines with different metastatic potential in a Matrigel invasion assay. alpha-MSH potently blocked the invasion of B16-BL6 cells with highly metastatic potential in a concentration-dependent manner, whereas it was less effective in inhibiting the invasion of weakly metastatic B16-F1 cells. Pretreatment of B16-BL6 cells with alpha-MSH resulted in a decrease of the adhesiveness to fibronectin and laminin substrates in a time-dependent fashion. As assessed by zymographic analysis, alpha-MSH partially inhibited the production of matrix metalloproteinase (MMP)-2 and -9 from both cell lines to a similar degree without affecting the degradative activity of these MMPs. alpha-MSH was more potent in inhibiting the migration of B16-BL6 cells towards both fibronectin- and laminin-coated substrates than that of B16-F1 cells. The growth and morphology of B16-BL6 cells were not changed after a 7-day incubation with alpha-MSH. The number of lung tumor colonies markedly decreased when B16-BL6 cells were coinjected intravenously with 10(-6) M alpha-MSH. However, alpha-MSH had no effect on the experimental lung metastases by B16-F1 cells. These results suggest that alpha-MSH suppressed the invasive and metastatic properties of B16 melanoma cells, and the degree of inhibition was associated with metastatic potential of B16 melanoma cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9561027

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  10 in total

1.  Social isolation stress augments angiogenesis induced by colon 26-L5 carcinoma cells in mice.

Authors:  W Wu; J Murata; K Murakami; T Yamaura; K Hayashi; I Saiki
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Authors:  Artur Wnorowski; Mariola Sadowska; Rajib K Paul; Nagendra S Singh; Anna Boguszewska-Czubara; Lucita Jimenez; Kotb Abdelmohsen; Lawrence Toll; Krzysztof Jozwiak; Michel Bernier; Irving W Wainer
Journal:  Cell Signal       Date:  2015-02-20       Impact factor: 4.315

3.  Melanogenic effect of dersimelagon (MT-7117), a novel oral melanocortin 1 receptor agonist.

Authors:  T Suzuki; Y Kawano; A Matsumoto; M Kondo; K Funayama; S Tanemura; M Miyashiro; A Nishi; K Yamada; M Tsuda; A Sato; K Morokuma; Y Yamamoto
Journal:  Skin Health Dis       Date:  2021-11-29

4.  Syndecan-2 regulates the migratory potential of melanoma cells.

Authors:  Jung-hyun Lee; Haein Park; Heesung Chung; Sojoong Choi; Younghwa Kim; Hyun Yoo; Tae-Yoon Kim; Hoo-Jae Hann; Ikjoo Seong; Jaesang Kim; Kathleen G Kang; Inn-Oc Han; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2009-07-29       Impact factor: 5.157

5.  Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.

Authors:  Ikjoo Seong; Hyun Jung Min; Jung-Hyun Lee; Chang-Yeol Yeo; Dong Min Kang; Eok-Soo Oh; Eun Sook Hwang; Jaesang Kim
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 6.  Neuroendocrine Factors in Melanoma Pathogenesis.

Authors:  Cristian Scheau; Carmen Draghici; Mihaela Adriana Ilie; Mihai Lupu; Iulia Solomon; Mircea Tampa; Simona Roxana Georgescu; Ana Caruntu; Carolina Constantin; Monica Neagu; Constantin Caruntu
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

7.  Anti-inflammatory and anti-invasive effects of alpha-melanocyte-stimulating hormone in human melanoma cells.

Authors:  P Eves; J Haycock; C Layton; M Wagner; H Kemp; M Szabo; R Morandini; G Ghanem; J C García-Borrón; C Jiménez-Cervantes; S Mac Neil
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

8.  Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells.

Authors:  Siddik Sarkar; Shashi Rajput; Amit Kumar Tripathi; Mahitosh Mandal
Journal:  Mol Cancer       Date:  2013-10-20       Impact factor: 27.401

9.  Gene expression regulation by agonist-independent constitutive signaling of melanocortin-1 receptor.

Authors:  Ikjoo Seong; Jaesang Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-06-26

10.  Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival.

Authors:  Rita G Kansal; Matthew S McCravy; Jacob H Basham; Joshua A Earl; Stacy L McMurray; Chelsey J Starner; Michael A Whitt; Lorraine M Albritton
Journal:  Oncotarget       Date:  2016-05-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.